Standard Chemotherapy vs. Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Glioblastoma

Clinical trial NCT03632135 · COMPLETED

Trial details

NCT number: NCT03632135
Sponsor: Cordgenics, LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Recurrent Glioblastoma

Start date: 2018-05-20
Primary completion: 2022-06-16
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.